Search results
4 days ago · Qing-Shui Zheng MD, Yong Wei MD, Xue-Yi Xue MD & Ning Xu MD. 1 Access. Explore all metrics. Article PDF. Author information. Bo-Han Lin, Shao-Hao Chen, and Zhong-Tian Ruan have contributed equally to this work. Authors and Affiliations.
5 days ago · Read more to learn about Xu Zeng, MD's background, education, and other specialties.
5 days ago · Background. Unsuccessful recanalisation or reocclusion after thrombectomy is associated with poor outcomes in patients with large vessel occlusion (LVO) acute ischaemic stroke (LVO-AIS). Bailout angioplasty or stenting (BAOS) could represent a promising treatment for these patients.
5 days ago · Neoadjuvant targeted therapy is not currently recommended because of insufficient evidence, characterized by a low depth of pathological response and no reported improvement in survival outcomes. The same is true for neoadjuvant immunotherapy in patients with EGFR mutations.
5 days ago · Lei Zheng, MD, PhD — an alumnus of The University of Texas Health Science Center at San Antonio — has been appointed executive director of the Mays Cancer Center and vice president for oncology for the health science center, effective Sept. 1. Zheng will also be named the Mays Family Foundation Distinguished University Presidential Chair of ...
2 days ago · Diffuse midline glioma (DMG), H3 K27M-mutant is a type of diffuse high-grade glioma that occurs in the brain midline carrying an extremely poor prognosis under the best efforts of surgery, radiation, and other... Yu-An Li, Chuan Zhao, Jing-Jing Ge, Cheng Li, Feng-Jun Xue, Shao-Pei Qi, Chi Zhao, Chen-Chen Kong and Jun-Ping Zhang.
4 days ago · Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular carcinoma. Xianzhou Zhang. Peng Zheng. Suxia Luo.
